Ascent Rift Valley Fund II LP has acquired a significant equity stake in Valley Hospital Limited in Nakuru, Kenya, marking its entry into the healthcare sector and highlighting a strategic commitment to enhance healthcare service delivery in the region.
Information on the Target
Ascent Rift Valley Fund II LP, a prominent East African private equity firm, has announced the acquisition of a significant equity stake in Valley Hospital Limited, located in Nakuru Town, Nakuru County, Kenya. Founded in 1996, Valley Hospital was among the first private for-profit hospitals in Nakuru, establishing itself as a pioneer in providing quality and affordable medical services to the local community. With a capacity of 75 beds, the hospital is fully accredited by all major players in the insurance industry, solidifying its status as a key healthcare provider in Nakuru County.
Mrs. Lydia Obwanga, the Managing Director and co-founder of Valley Hospital, expressed her enthusiasm regarding the partnership with Ascent, stating that this collaboration is a significant milestone for Nakuru County. She emphasized that it will further reinforce the hospital's commitment to delivering high-quality healthcare to the residents of Nakuru.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Kenya
The healthcare sector in Kenya has undergone significant transformations over the past decade, driven by increasing demand for quality medical services, particularly in urban areas. With a growing population and ri
Similar Deals
AfricInvest → HewaTele
2025
Alta Semper → MYDAWA
2023
Proparco and Ascent Rift Valley Fund II → Diani Beach Hospital Limited
2022
Growth Lending → A & R Care Limited
2025
New Mountain Capital → Smarter Technologies
2025
InvAscent → Apex Hospitals Private Limited
2025
Ascent Rift Valley Fund II LP
invested in
Valley Hospital Limited
in 2023
in a Growth Equity & Expansion Capital deal